Splicing factor 3B subunit 1 (SF3B1) mutation in the context of therapy-related myelodysplastic syndromes. Volpe VO, Al Ali N, Chan O, Padron E, et al. Br J Haematol 2022;198:713-720.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Volpe VO, Al Ali N, Chan O, Padron E, et al. Splicing factor 3B subunit 1 (SF3B1) mutation in the context of therapy-related myelodysplastic syndromes. Br J Haematol 2022;198:713-720.
PMID: 35751140